http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Rubrik integrates with Microsoft Defender for identity attack response
-
New Microsoft and Rubrik Integration Delivers Complete Identity Attack Response
-
Rubrik launches AI governance engine for autonomous agents
-
22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026
-
RUMPLE MINZE ADDS A NEW CHAPTER TO ITS LORE WITH THE LAUNCH OF RUMPLE MINZE CINNAMINT WHISKEY
-
Immunexpress Presenting at the Society of Critical Care Medicine (SCCM) 2026 Critical Care Congress Showing SeptiCyte RAPID® High Correlation with Blood Culture Positive Sepsis Patients
-
22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026
-
Sue Ennis Joins Realbotix to Lead Direct-to-Consumer Business
-
Rubrik Rolls Out Industry’s First Semantic AI Governance Engine
-
On National Viagra Day, Women Finally Claim Their Turn:
-
OneSpan Named an Overall Leader in KuppingerCole Analyst’s Leadership Compass for Passwordless Authentication
-
Kobo Resources plans $5.5 million private placement for gold projects
-
Kobo Resources Announces Non-Brokered Private Placement of up to $5.5 Million to Advance Kossou and Regional Growth
-
Palvella hires Jennifer McDonough as market access VP
-
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
-
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservat
-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
-
Ford and Major League Baseball Unite to Celebrate America’s Pastime and the People Who Power It
-
ClearCompany Rebrands as ClearCo, Signaling Its Evolution into an AI- and Agent-Powered Unified Talent Platform
-
Core Scientific secures additional $500 million from J.P. Morgan
-
FDA grants priority review to Ionis' Alexander disease treatment
-
West Point Gold Expands the Ongoing Fully Funded Drill Program to 20,000m
-
Core Scientific Expands Strategic Financing Facility to $1 Billion with Additional $500 Million Commitment from J.P. Morgan
-
Q2 Metals Announces Multiple 200+ Metre Intervals of Continuous Spodumene Pegmatite and Provides an Update on the Inaugural Mineral Resource Estimate at the Cisco Lithium Project, Quebec, Canada
-
Cunard Announces Exclusive Partnership with Celebrity Fashion Stylist Micaela Erlanger
-
Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review
-
Victory Capital defends Janus Henderson acquisition proposal
-
Victory Capital Sets the Record Straight on Actionability of Its Clearly Superior Proposal to Acquire Janus Henderson
-
Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
-
APEMARS Stage 12 at $0.000125 Ends in 24 Hours: The Next Big Meme Coin After Dogecoin and Axie Infinity – Hurry or Miss Out
-
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026
-
Bitcoin Everlight Opens Phase 2 Presale as Shard Activations Continue Across All Three Tiers
-
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026
-
HII Celebrates 2025 Graduates of The Newport News Shipbuilding Apprentice School
-
Bitcoin Everlight Opens Phase 1 of Its Presale With Dual Audit and Dual KYC Verification Already in Place
-
THIRDREALITY Launches Matter-Enabled Smart Water Leak Sensor KM1, Offering Simple and Affordable Home Leak Protection
-
AELIS Farma starts recruitment for phase 2B down syndrome trial
-
Aelis Farma announces the successful start of the recruitment of the Phase 2B clinical trial with AEF0217 for the treatment of behavioral and cognitive impairments of people with Down syndrome (Trisom
-
Union Pacific Celebrates America’s 250th Anniversary with New Locomotives No. 4547 and No. 1776
-
Musk found liable to Twitter shareholders in fraud lawsuit over $44 billion takeover
-
Fobi AI completes $1.35 million private placement amid trading halt
-
Fobi AI Announces Completion Of Non-Brokered Private Placement
-
Jury says Musk misled Twitter investors before 2022 buyout, Bloomberg News reports
-
Tetreum Launches High-Performance Blockchain and Opens TET Token Presale
-
MAX Power Closes $20.5 Million Brokered Offering With Eric Sprott as Lead Order
-
Zoomex Outlines AI-Ready Liquidity and Execution Framework as Automated Trading Expands
-
Tourism, Philanthropy, and Championship Golf Take Center Stage at the Governor Albert Bryan Jr. Golf Classic Weekend in St. Croix
-
ImmunityBio receives approval for ANKTIVA in Macau for bladder cancer
-
ImmunityBio Announces Approval in Macau SAR, China for ANKTIVA® in BCG-Unresponsive NMIBC with CIS ± Papillary Tumors
